Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2156.8%
Neutral1643.2%
Bearish00.0%
1 unmapped firm rating excluded from the percentages.
TransDigm Group Incorporated · TDG · FY2026 Q1 · Calendar Q1 2026
TransDigm Beats Q1 Estimates, Raises FY26 Guidance, Announces $3.2B in Acquisitions
TransDigm opened FY26 with a Q1 beat — EPS $8.23 vs $8.10 estimated, revenue $2.285B vs $2.258B estimated — and raised full-year guidance. The stock nonetheless fell 9.3% on report day at 4.25x normal volume. Analysts focused on aftermarket revenue lagging distributor POS, margin dilution from $3.2B in new acquisitions, and integration risk. Management stayed confident, citing 17% commercial OEM growth, a 52.4% EBITDA margin, and a robust M&A pipeline.
Reported Before market openNYSEIndustrials
$73.16B market cap
100quality score
Company context
Snapshot as of publicationTransDigm Group Incorporated is a global aerospace enterprise specializing in the development, manufacturing, and distribution of a wide array of aircraft components. Operating across the United States and internationally, its business is structured around three distinct divisions. The Power & Control division focuses on critical systems, providing solutions such as electromechanical actuators and control mechanisms, engine ignition and related technologies, precision pumps and valves, power regulation equipment, specialized electric motors and generators, energy storage units, data communication and power management systems, diverse sensors, switching gear, and material handling equipment including hoists and cargo systems. This segment caters to a broad clientele, including engine and power system manufacturers, airlines, independent maintenance providers, governmental defense agencies, and aircraft repair facilities. The Airframe segment delivers structural and interior components.…
Earnings scorecard
Reported versus consensus
Reported EPS
$8.23
Consensus $8
EPS surprise
+1.6%
Reported versus consensus
Reported revenue
$2.29B
Consensus $2.26B
Revenue surprise
+1.2%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$1,283.78Current
$660Low
$1,373.42Average
$1,871High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Overweight | Downgrade | Jul 15, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 2, 2026 |
| UBS | Buy | Buy | Maintain | May 6, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | May 6, 2026 |
| Stifel | Buy | Buy | Maintain | May 6, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 6, 2026 |
| Keybanc | Overweight | Downgrade | Feb 5, 2026 | |
| JP Morgan | Neutral | Neutral | Maintain | Nov 14, 2025 |
| Truist Securities | Buy | Buy | Maintain | Oct 15, 2025 |
| Jefferies | Buy | Buy | Maintain | Sep 17, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jun 23, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | May 8, 2025 |
| Barclays | Equal Weight | Overweight | Downgrade | Jan 6, 2025 |
| Deutsche Bank | Hold | Buy | Downgrade | Jan 2, 2025 |
| B of A Securities | Buy | Buy | Maintain | May 29, 2024 |
| TD Cowen | Buy | Buy | Maintain | May 8, 2024 |
| Baird | Outperform | Outperform | Maintain | May 8, 2024 |
| Alembic Global | Neutral | Overweight | Downgrade | Nov 16, 2023 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 9, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 22, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 8, 2023 |
| Vertical Research | Buy | Buy | Maintain | Sep 6, 2022 |
| Canaccord Genuity | Buy | Buy | Maintain | May 12, 2021 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Jul 15, 2020 |
| Bank of America | Buy | Buy | Maintain | Dec 4, 2019 |
| Longbow Research | Neutral | Neutral | Maintain | Apr 9, 2019 |
| Berenberg | Buy | Buy | Maintain | Sep 28, 2018 |
| Stephens & Co. | Equal Weight | Underweight | Upgrade | Feb 8, 2018 |
| Wellington Shields | Hold | Gradually Accumulate | Downgrade | Nov 15, 2016 |
| FBR Capital | Sector Perform | Sector Perform | Maintain | Aug 21, 2015 |
| CRT Capital | Buy | Buy | Maintain | Feb 24, 2015 |
| DA Davidson | Neutral | Neutral | Maintain | Nov 13, 2014 |
| Great Lakes | Hold | Gradually Accumulate | Downgrade | Jan 13, 2014 |
| Imperial Capital | Outperform | Outperform | Maintain | May 8, 2013 |
| Topeka | Hold | Hold | Maintain | Sep 27, 2012 |
| Wedbush | Neutral | Neutral | Maintain | May 9, 2012 |
| Auriga | Buy | Buy | Maintain | Mar 30, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $1,283.78. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $1,345 | $1,215.34 | +4.8% | Jul 15, 2026 |
| Jefferies | Analyst unavailable | $1,575 | $1,215.08 | +22.7% | May 10, 2026 |
| UBS | Analyst unavailable | $1,645 | $1,240.1 | +28.1% | May 6, 2026 |
| RBC Capital | Ken Herbert | $1,350 | $1,191.33 | +5.2% | May 6, 2026 |
| Morgan Stanley | Analyst unavailable | $1,680 | $1,191.33 | +30.9% | May 6, 2026 |
| Stifel Nicolaus | Analyst unavailable | $1,525 | $1,191.33 | +18.8% | May 6, 2026 |
| Jefferies | Analyst unavailable | $1,565 | $1,285.53 | +21.9% | Feb 8, 2026 |
| Susquehanna | Charles Minervino | $1,400 | $1,251.75 | +9.1% | Feb 4, 2026 |
| BMO Capital | Analyst unavailable | $1,550 | $1,301.93 | +20.7% | Feb 4, 2026 |
| UBS | Analyst unavailable | $1,800 | $1,301.93 | +40.2% | Feb 4, 2026 |
| Robert W. Baird | Analyst unavailable | $1,400 | $1,301.93 | +9.1% | Feb 4, 2026 |
| Goldman Sachs | Noah Poponak | $1,871 | $1,450 | +45.7% | Jan 20, 2026 |
| Susquehanna | Analyst unavailable | $1,500 | $1,428.44 | +16.8% | Jan 15, 2026 |
| UBS | Gavin Parsons | $1,804 | $1,428.39 | +40.5% | Jan 15, 2026 |
| Truist Financial | Michael Ciarmoli | $1,697 | $1,377.42 | +32.2% | Jan 9, 2026 |
| Morgan Stanley | Analyst unavailable | $1,660 | $1,330.3 | +29.3% | Nov 14, 2025 |
| Truist Financial | Michael Ciarmoli | $1,647 | $1,270.08 | +28.3% | Oct 15, 2025 |
| Morgan Stanley | Kristine Liwag | $1,600 | $1,306.32 | +24.6% | Oct 15, 2025 |
| Susquehanna | Analyst unavailable | $1,450 | $1,285.85 | +12.9% | Oct 9, 2025 |
| Deutsche Bank | Analyst unavailable | $1,370 | $1,284.38 | +6.7% | Oct 8, 2025 |
| BMO Capital | Michael Goldie | $1,420 | $1,289.29 | +10.6% | Sep 29, 2025 |
| Jefferies | Sheila Kahyaoglu | $1,490 | $1,275.96 | +16.1% | Sep 17, 2025 |
| Susquehanna | Charles Minervino | $1,600 | $1,574.85 | +24.6% | Jul 14, 2025 |
| Deutsche Bank | Scott Deuschle | $1,545 | $1,524.23 | +20.3% | Jul 8, 2025 |
| Stifel Nicolaus | Jonathan Siegmann | $1,710 | $1,470.68 | +33.2% | Jun 23, 2025 |
| Truist Financial | Michael Ciarmoli | $1,553 | $1,391.86 | +21.0% | May 7, 2025 |
| Susquehanna | Charles Minervino | $1,300 | $1,399.57 | +1.3% | Apr 2, 2025 |
| Wells Fargo | Matthew Akers | $1,580 | $1,394.11 | +23.1% | Mar 25, 2025 |
| Deutsche Bank | Scott Deuschle | $1,348 | $1,254.11 | +5.0% | Jan 2, 2025 |
| Morgan Stanley | Kristine Liwag | $1,575 | $1,237.37 | +22.7% | Aug 7, 2024 |
| RBC Capital | Ken Herbert | $1,500 | $1,321.83 | +16.8% | Jun 24, 2024 |
| Deutsche Bank | Scott Deuschle | $1,524 | $1,339.48 | +18.7% | Jun 20, 2024 |
| Stifel Nicolaus | Bert Subin | $1,325 | $1,325.75 | +3.2% | Jun 7, 2024 |
| KeyBanc | Michael Leshock | $1,440 | $1,338 | +12.2% | May 28, 2024 |
| Morgan Stanley | Analyst unavailable | $793 | $742.5 | -38.2% | Feb 8, 2023 |
| Morgan Stanley | Analyst unavailable | $765 | $611.3 | -40.4% | Dec 12, 2022 |
| Wells Fargo | Analyst unavailable | $660 | $636.54 | -48.6% | Nov 28, 2022 |
| Wells Fargo | Analyst unavailable | $735 | $640.02 | -42.7% | Nov 11, 2022 |
| Bank of America Securities | Ronald Epstein | $790 | $625.25 | -38.5% | Nov 23, 2021 |
| Barclays | David E. Strauss | $710 | $629.63 | -44.7% | Nov 22, 2021 |
| Cowen & Co. | Gautam Khanna | $695 | $660.61 | -45.9% | Nov 18, 2021 |
| Susquehanna | Charles Minervino | $708 | $658.93 | -44.9% | Nov 17, 2021 |
| Goldman Sachs | Noah Poponak | $732 | $599.56 | -43.0% | Sep 10, 2021 |
| Credit Suisse | Robert Spingarn | $712 | $629.11 | -44.5% | Aug 6, 2021 |
| Wells Fargo | Matthew Akers | $718 | $578.24 | -44.1% | May 12, 2021 |
Track every rating change on TDG the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session close
Stock move
-9.3%
Event window
SPY move
-0.8%
Same window
Abnormal move
-8.5%
Stock minus SPY
Volume
4.3×
Versus trailing sessions
Subsequent drift
+1.0%
Up to 20 sessions
TDGSPY benchmark
Follow TDG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
FY26 sales guidance midpoint raised from $9.85B to $9.94B; EBITDA midpoint raised from $5.15B to $5.21B. Three new acquisitions announced totaling ~$3.2B (Stellant Systems ~$960M, Jet Parts Engineering and Victor Sierra ~$2.2B). Commercial OEM grew 17% YoY while aftermarket lagged distributor POS. Q1 free cash flow of ~$900M exceeded typical conversion. New defense contracts: $24M DoD floating decoy systems and a Lockheed Martin antenna system contract. Cash balance declined to $2.5B from $2.8B in the prior quarter, reflecting acquisition activity.
Guidance delta
Raised. FY26 sales midpoint increased from $9.85B to $9.94B; EBITDA midpoint increased from $5.15B to $5.21B. Guidance sentiment: raised.
Key takeaways
- Q1 EPS of $8.23 beat consensus of $8.10 by 1.6%; revenue of $2.285B beat the $2.258B estimate by 1.2%
- EBITDA margin held at 52.4% despite acquisition-related dilution
- FY26 guidance raised: sales midpoint to $9.94B, EBITDA midpoint to $5.21B
- Three pending acquisitions totaling ~$3.2B: Stellant Systems (~$960M), Jet Parts Engineering and Victor Sierra Aviation (~$2.2B)
- Commercial OEM grew 17% YoY on Boeing and Airbus production recovery; aftermarket lagged due to engine exposure and inventory lumpiness
- Q1 cash balance of $2.5B; free cash flow just under $900M exceeded typical conversion
Management priorities
- Close pending acquisitions of Stellant Systems, Jet Parts Engineering, and Victor Sierra Aviation
- Continue disciplined small- to midsize M&A pipeline
- Reinvest in operating units and pursue cost-efficiency initiatives
- Return excess capital via share buybacks and potential dividends
- Monitor OEM production trends and adjust guidance as needed
Related earnings events
IndustrialsURI · FY2026 Q2 · Calendar Q3 2026United Rentals Q2: Record Revenue, Raised Guidance, and a Possible Investment-Grade UpgradeNSC · FY2026 Q2 · Calendar Q3 2026Norfolk Southern Beats on Volume Strength as Intermodal and Coal Drive Q2 GrowthHON · FY2026 Q2 · Calendar Q3 2026Honeywell Q2: Beat and Raise as Portfolio Reshaping Nears Completion
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-29T13:11:23.719289+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T13:11:23.716916+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.